Daniel Horák Selected Research

seryl- isoleucyl- lysyl- valyl- alanyl- valinamide

6/2018	Dynamics of tissue ingrowth in SIKVAV-modified highly superporous PHEMA scaffolds with oriented pores after bridging a spinal cord transection.
11/2015	SIKVAV-modified highly superporous PHEMA scaffolds with oriented pores for spinal cord injury repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Horák Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 01/2002
4	Spinal Cord Injuries (Spinal Cord Injury) 08/2018 - 12/2011
3	Glioblastoma (Glioblastoma Multiforme) 04/2022 - 01/2020
3	Multiple Sclerosis 04/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2013
2	Carcinoma (Carcinomatosis) 11/2021 - 12/2017
2	Leukemia 02/2021 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 05/2015 - 11/2014
1	Infections 07/2022
1	Adenocarcinoma 11/2021
1	Anaphylaxis (Anaphylactic Shock) 11/2021
1	Body Weight (Weight, Body) 05/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021
1	Stroke (Strokes) 01/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Epilepsy (Aura) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Necrosis 12/2017
1	Carcinosarcoma 01/2017
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Inflammation (Inflammations) 08/2015
1	Circulating Neoplastic Cells 01/2013
1	Arteriovenous Malformations (Arteriovenous Malformation) 03/2008
1	Fistula 03/2008
1	Hemorrhage 01/2002
1	Wounds and Injuries (Trauma) 01/2002

Drug/Important Bio-Agent (IBA)

6	Polyhydroxyethyl Methacrylate (PHEMA)IBA 06/2018 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 07/2022 - 05/2015
4	HydrogelsIBA 08/2018 - 12/2011
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2018
3	polyglycidyl methacrylateIBA 01/2018 - 01/2013
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 01/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2021 - 12/2017
2	poly(N,N-dimethylacrylamide)IBA 11/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
2	methacrylamideIBA 01/2020 - 01/2018
2	seryl- isoleucyl- lysyl- valyl- alanyl- valinamideIBA 06/2018 - 11/2015
2	Immunoglobulin G (IgG)IBA 01/2017 - 01/2013
2	Peptides (Polypeptides)IBA 08/2016 - 11/2014
1	Troponin IIBA 07/2022
1	AntioxidantsIBA 04/2022
1	Tannic Acid FDA Link 04/2022
1	ImmunosorbentsIBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	OxidesIBA 11/2021
1	IronIBA 11/2021
1	Tyrosine (L-Tyrosine)FDA Link 11/2021
1	Photosensitizing Agents (Photosensitizers)IBA 11/2021
1	Superoxides (Superoxide)IBA 05/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2021
1	Myosins (Myosin)IBA 04/2021
1	hydroxyethyl methacrylate (HEMA)IBA 02/2021
1	SuspensionsIBA 01/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Trypan Blue FDA Link 01/2020
1	LipidsIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	HydrazonesIBA 01/2020
1	AcidsIBA 01/2020
1	Caseins (Casein)FDA Link 11/2019
1	Antineoplastic Agents (Antineoplastics)IBA 11/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	MethacrylatesIBA 08/2018
1	Biocompatible Materials (Biomaterials)IBA 06/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Biological ProductsIBA 01/2018
1	CarbodiimidesIBA 01/2018
1	Dacarbazine (DIC)FDA LinkGeneric 01/2018
1	GlycoconjugatesIBA 01/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	Staphylococcal Protein A (Protein A)IBA 01/2018
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2018
1	phthalocyanineIBA 12/2017
1	AntibodiesIBA 01/2017
1	Tocopherols (Tocopherol)IBA 01/2017
1	GoldIBA 05/2015
1	Amyloid (Amyloid Fibrils)IBA 11/2014
1	Acetates (Acetic Acid Esters)FDA Link 01/2013
1	Epithelial Cell Adhesion MoleculeIBA 01/2013
1	AlbuminsIBA 01/2013
1	Immobilized AntibodiesIBA 01/2013
1	CholesterolIBA 12/2011

Therapy/Procedure

5	Microspheres (Microsphere) 01/2018 - 01/2013
3	Therapeutics 01/2019 - 01/2016
2	Photochemotherapy (Photodynamic Therapy) 11/2021 - 12/2017
2	Precision Medicine 01/2018 - 11/2017
1	Intravenous Administration 05/2021
1	Lasers (Laser) 12/2017
1	Nanospheres 12/2017
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2015